Dr. Prasanth Manohar, Ph.D., – Page 16 – PHAGElogist

Special issue on “Bacterial defense systems”

30 Jul 202330 Jul 2023

I will be serving as a guest editor for the special issue to be published in BMC Microbiology. If you are working on bacterial defense system, this issue is for…

Phage cocktail against Klebsiella pneumoniae infection

Phage therapy has potential to combat antibiotic-resistant bacteria causing bovine mastitis. Our objective was to use 3 Klebsiella lytic phages to create a phage cocktail, and to compare bactericidal activity of this phage cocktail versus an…

Phage Therapy: Turning Viruses into Antibiotics

For decades, humanity has waged war against viruses. Yet, in a strange twist of fate, we find ourselves exploring the possibility of harnessing these microscopic adversaries to our benefit. In…

Phage Therapy for Diabetic Foot Infection

Phage Therapy for Diabetic Foot Infection: A Case Series in Clinical Therapeutics https://doi.org/10.1016/j.clinthera.2023.06.009 Abstract Purpose Infected diabetic foot ulcers can be difficult to treat and, despite appropriate antibiotic therapy, some…

My first publication from Texas A&M University

Escherichia fergusonii strain RY44, whole genome shotgun sequencing project Title: Isolation of E. fergusonii from poultry ceca samples in College Station, Texas https://www.ncbi.nlm.nih.gov/nuccore/JASJUP000000000

Get Cured with Phage Therapy

Patients in India who need alternative therapy to treat antibiotic resistant infections can reach out to us. We will help you to get compassionate phage therapy. Stay tuned for the…

Bacteriophage therapy to treat primary sclerosing cholangitis

Another interesting study on phage therapy : "Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis" Nature Communications volume 14, Article number: 3261 (2023) Abstract Primary sclerosing cholangitis (PSC) is characterized by progressive…

Phage Therapy: An Observation Study

A retrospective, observational study of 12 cases of expanded access customized phage therapy: production, characteristics, and clinical outcomes Clinical Infectious Diseases, ciad335 Abstract Background Antibiotic resistance (AMR) is undermining modern…

Non-alcoholic fatty liver disease: Bacteriophages to treat Klebsiella pneumoniae

Abstract Our previous studies have shown that high alcohol-producing Klebsiella pneumoniae (HiAlc Kpn) in the intestinal microbiome could be one of the causes of non-alcoholic fatty liver disease (NAFLD). Considering antimicrobial resistance of K.…

Advancements in bacteriophage therapies

Advancements in bacteriophage therapies and delivery for bacterial infection DOI: 10.1039/D2MA00980C (Review Article) Mater. Adv., 2023, 4, 1249-1257 Abstract Having co-evolved with bacteria over hundreds of millions of years, bacteriophage are effective killers of…